Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster

Group 1 - The article discusses the author's first treatment of Omeros in 2025, following extensive coverage in the previous year [1] - The author emphasizes the learning process involved in investing, viewing failures as tuition and successes as lessons learned, particularly in the healthcare sector [2] - The author has a beneficial long position in Omeros shares, indicating a personal investment interest [3] Group 2 - The author may engage in buying or selling shares of any mentioned company within the next 72 hours, suggesting potential volatility or changes in position [4] - Seeking Alpha clarifies that past performance does not guarantee future results and that no specific investment advice is being provided [5]